Adverse Effects of Antituberculosis Drugs

This publication has 100 references indexed in Scilit:

• Pyridoxine supplementation during isoniazid therapy
  Tubercle, 1980
• Interaction of rifampicin with other drugs
  Tubercle, 1980
• Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration
  Tubercle, 1979
• The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide
  Tubercle, 1977
• Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months
  Tubercle, 1976
• Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin
  Tubercle, 1974
• Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa: Second report: A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils
  Tubercle, 1973
• Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research Council
  Tubercle, 1973
• The rifampicins in purulent bronchitis
  Tubercle, 1969
• Isoniazid with thiacetazone (Thioacetazone) in the treatment of pulmonary tuberculosis in East Africa—third investigation: The effect of an initial streptomycin supplement: A co-operative study in East African hospitals and laboratories with the collaboration of the East African and British medical research councils
  Tubercle, 1966